First test of new drug in healthy volunteers
NCT ID NCT06577337
Summary
This is an early-stage study to check the safety of a new drug called M5542 when given as an injection to healthy people. Researchers will give different doses to small groups of participants and closely monitor for any side effects. The main goal is to see how the body handles the drug and if it causes any safety issues before testing it in people with a specific disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Pharmacology Unit of Nuvisan GmbH
RECRUITINGNeu-Ulm, Germany
Conditions
Explore the condition pages connected to this study.